Platelet monoamine oxidase activity in obsessive-compulsive disorder

Area of Science:

• Neuroscience
• Psychiatry
• Biochemistry

Background:

• Selective serotonin reuptake inhibitors (SSRIs) suggest serotonergic system involvement in obsessive-compulsive disorder (OCD).
• Previous biological studies on serotonergic function in OCD have produced conflicting findings.
• Platelet monoamine oxidase (MAO) activity is a potential biomarker for central serotonin activity.

Purpose of the Study:

• To investigate platelet MAO activity in individuals with OCD compared to healthy controls.
• To explore the association between platelet MAO activity and OCD symptom severity.
• To examine the relationship between platelet MAO activity and aggressive obsessions in OCD patients.

Main Methods:

• Assessed platelet MAO activity in 29 OCD patients and 29 matched healthy controls.
• Utilized the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) to measure OCD severity.
• Compared MAO activity levels between patient and control groups, and correlated MAO activity with Y-BOCS scores and aggressive obsessions.

Main Results:

• No significant difference in platelet MAO activity was observed between OCD patients and healthy controls.
• A significant positive correlation was found between platelet MAO activity and Y-BOCS scores in OCD patients with scores exceeding 15.
• OCD patients exhibiting aggressive obsessions demonstrated significantly lower platelet MAO activity compared to those without aggressive obsessions.

Conclusions:

• Platelet MAO activity may serve as a biomarker for OCD severity.
• Lower platelet MAO activity appears to be associated with the presence of aggressive obsessions in OCD.
• Findings contribute to understanding the complex role of the serotonergic system in OCD pathophysiology.